Nectar Lifesciences Limited — Dividend/Bonus, 10-12-2025: Public Announcement - Buyback of Shares

Nectar Lifesciences has issued a corrigendum related to its equity share buyback public announcement. The provided document confirms the corrigendum's publication in newspapers. However, this specific release does not contain the key details of the buyback, such as the total buyback size, price per share, the method (e.g., tender offer or open market), or the full timeline. Therefore, the requested buyback figures and structural impact cannot be summarized from the available information.